The U.S. Food and Drug Administration (FDA) has granted orphan drug status to…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
Only two non-invasive diagnostic tests are required to best predict the risk of adverse events in people with…
Targeting Feedback Signaling Mechanism Involved in Vascular Remodeling May Prevent PH, Study Finds
Disrupting the vascular remodeling feedback signaling loop mediated by CD146-HIF-1α can effectively prevent the development of…
Blocking the protein interleukin-1 (IL-1) protects against pulmonary hypertension (PH) induced by complications…